Abstract: The present application relates to a spectral restoring method, including: acquiring a light energy response signal matrix output by a photosensitive chip of a spectral imaging device and a standard spectrum; determining a primitive restoring function and a response signal vector of the primitive restoring function based on the light energy response signal matrix, the primitive restoring function restoring a spectral image value of a predetermined channel corresponding thereto using a predetermined pixel value of the photosensitive chip and pixel values in the vicinity thereof; acquiring a restoring tensor, the product of the restoring tensor and the response signal vector being equal to an output of the primitive restoring function based on the response signal vector; and obtaining a restored spectral image based on the product of the restoring tensor and the response signal vector.

Abstract: An ultrasound imaging system may acquire an image of a liver. The liver may be segmented from the image. Parameters, such as image homogeneity map, intensity probability chart, and/or speckle size diagram, may be extracted from the liver portion of the image. The parameters may be used to determine whether fatty liver deposits are diffuse or inhomogeneous. In some examples, inhomogeneous regions may be excluded from the calculation of liver fat quantification measurements. In some examples, the inhomogeneous regions may be displayed so that a user may select a region of interest that excludes the inhomogeneous regions to calculate the liver fat quantification measurements.

Abstract: Selectively rewriting URLs is disclosed. An indication is received that a message has arrived at a user message box. A determination is made that the message includes a first link to a first resource. The first link is analyzed to determine whether the first link is classified as a non-rewrite link. In response to determining that the first link is not classified as a non-rewrite link, a first replacement link is generated for the first link.

Abstract: The present application relates to a spectral restoring method, including: acquiring a light energy response signal matrix output by a photosensitive chip of a spectral imaging device and a standard spectrum; determining a primitive restoring function and a response signal vector of the primitive restoring function based on the light energy response signal matrix, the primitive restoring function restoring a spectral image value of a predetermined channel corresponding thereto using a predetermined pixel value of the photosensitive chip and pixel values in the vicinity thereof; acquiring a restoring tensor, the product of the restoring tensor and the response signal vector being equal to an output of the primitive restoring function based on the response signal vector; and obtaining a restored spectral image based on the product of the restoring tensor and the response signal vector.

Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to a compound having the following formula, or a stereoisomer thereof, a prodrug thereof, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, preparation method thereof, pharmaceutical composition comprising the same and use of the compound in the manufacture of a medicament for preventing or treating tumor, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.

Abstract: The present invention relates to thienopyrimidine compound, preparation method thereof, pharmaceutical composition and use thereof, and in particular to a type of compounds having ALK and/or c-Met selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for preventing or treating a disease associated with anaplastic lymphoma kinase in vivo, and in the manufacture of a medicament for preventing or treating a disease associated with angiogenesis or cancer metastasis, in particular in the manufacture of a medicament for preventing or treating tumor growth and metastasis.

Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.

Abstract: The method is for channel estimation with transmitter (Tx) and receiver (Rx) beam training in an OFDMA HBF system wherein the transmitter and receiver communicate over a channel and each include a plurality of Radio Frequency (RF) chains and an antenna array of antenna elements corresponding to each RF chain, and wherein the transmitter includes an analog beamformer and the receiver includes an analog combiner. The method includes generating a set of orthogonal Tx training beams for the transmitter based upon a number of antenna elements in the transmitter antenna array, and generating a set of orthogonal Rx training beams for the receiver based upon a number of antenna elements in the receiver antenna array.